Form 4 for ALB Albemarle Corporation
Accepted 2025-01-03 00:00:00 ET · period of report 2024-12-31 · accession 0000915913-25-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-03 | 2024-12-31 | ALB | Masters J Kent | COB, CEO, Dir | F - Tax | $86.08 | -192 | 105.2K | -0.2% | -$16.5K |
| D | 2025-01-03 | 2024-12-31 | ALB | Masters J Kent | COB, CEO, Dir | M - OptEx | $0.00 | +434 | 105.4K | +0.4% | $0 |
| D | 2025-01-03 | 2024-12-31 | ALB | Masters J Kent | COB, CEO, Dir | M - OptEx | $0.00 | -434 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-31 | F | D | 192 | $86.08 | 105,164 | D | — | — | (F2) Shares withheld to meet tax liabilities associated with vesting of RSUs. (F1) The Reporting Person's holdings reported in Table 1, Column 5 include: 10,020 Restricted Stock Units ("RSUs") granted on February 24, 2023, and 21,155 RSUs granted on February 22, 2024, which were previously reported in Table 2 in Forms 4 filed 2/28/2023 and 2/26/2024, respectively. These RSUs will vest 100% on the earlier of 12/31/2025 or the date a successor Chief Executive Officer commences employment with the Issuer (subject to the terms of the applicable award agreement). Starting with this report, RSUs subject to time-based vesting conditions will be reported in Table 1 at grant and in Column 5 as beneficially owned for consistency in reporting methodology amongst reporting persons of the Issuer. |
| 2 | Common | Common Stock | 2024-12-31 | M | A | 434 | $0.00 | 105,356 | D | — | — | (F1) The Reporting Person's holdings reported in Table 1, Column 5 include: 10,020 Restricted Stock Units ("RSUs") granted on February 24, 2023, and 21,155 RSUs granted on February 22, 2024, which were previously reported in Table 2 in Forms 4 filed 2/28/2023 and 2/26/2024, respectively. These RSUs will vest 100% on the earlier of 12/31/2025 or the date a successor Chief Executive Officer commences employment with the Issuer (subject to the terms of the applicable award agreement). Starting with this report, RSUs subject to time-based vesting conditions will be reported in Table 1 at grant and in Column 5 as beneficially owned for consistency in reporting methodology amongst reporting persons of the Issuer. |
| 3 | Derivative | Restricted Stock Units | 2024-12-31 | M | D | 434 | $0.00 | 0 | D | — · — to — | 434 Common Stock | (F3) Each RSU converts to 1 share of Common Stock. (F4) RSUs granted on 02/25/2022. 95% vested on 12/31/2023 and remaining 5% vested on 12/31/2024. (F5) No expiration date. |